Phase II Study of the Trifunctional Bispecific Anti-HER-

  • Haddad, Tufia (PI)

Project: Research project

Project Details

Description

Phase II Study of the Trifunctional Bispecific Anti-HER-2/Neu x Anti-CD3 Antibody Ertumaxomab in Patients with HER-2/Neu Overexpressing (3+ or 2+/FISH+) Metastatic Breast
StatusFinished
Effective start/end date6/1/07 → 12/31/10

Funding

  • FRESENIUS BIOTECH NORTH AMERICA INC